High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area
- PMID: 2021946
High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area
Abstract
Using polymerase chain reaction and sequence-specific oligonucleotide hybridization, the frequency of three ras oncogene mutations (N-ras, Ha-ras, and K-ras) in thyroid tumors (25 adenomas, 16 follicular carcinomas, and 22 papillary carcinomas) was investigated in both iodide-deficient and iodide-sufficient areas. The ras oncogene mutation rate was significantly higher in the iodide-deficient area, being 85 versus 17% in the adenomas, and 50 versus 10% in the follicular carcinomas. No mutations were found in papillary carcinomas. The most common mutation site was Ha-ras codon 61 with Gln----Arg substitution. Two ras mutations at codon 61 (Gln----Lys in N-ras and Gln----Arg in Ha-ras) were found in a microfollicular adenoma specimen from Eastern Hungary. We conclude that dietary iodine may modulate ras oncogene mutations, and that in the iodide-deficient area, ras oncogene activation may play a more important role in the initiation and/or maintenance of follicular tumors. Additional factors are, however, necessary to initiate carcinogenesis.
Similar articles
-
Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.Ann Biol Clin (Paris). 1995;53(10-11):549-55. Ann Biol Clin (Paris). 1995. PMID: 8787281
-
N-ras 61 oncogene mutations in Hürthle cell tumors.Surgery. 1990 Dec;108(6):994-9; discussion 999-1000. Surgery. 1990. PMID: 2247846
-
Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.Oncogene. 1996 Aug 15;13(4):687-93. Oncogene. 1996. PMID: 8761289
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
-
[Unique association of p53 mutations with undifferentiated carcinoma of the thyroid].Nihon Rinsho. 1994 Apr;52(4):1069-74. Nihon Rinsho. 1994. PMID: 8196165 Review. Japanese.
Cited by
-
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10. Thyroid. 2014. PMID: 24798740 Free PMC article.
-
Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.Cancer Res. 2009 Apr 15;69(8):3689-94. doi: 10.1158/0008-5472.CAN-09-0024. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351816 Free PMC article.
-
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.Thyroid Res. 2015 Jun 18;8:8. doi: 10.1186/s13044-015-0020-8. eCollection 2015. Thyroid Res. 2015. PMID: 26146517 Free PMC article.
-
Genetic Alterations in Hungarian Patients with Papillary Thyroid Cancer.Pathol Oncol Res. 2016 Jan;22(1):27-33. doi: 10.1007/s12253-015-9969-9. Epub 2015 Aug 11. Pathol Oncol Res. 2016. PMID: 26259532
-
Molecular pathobiology of thyroid neoplasms.Endocr Pathol. 2002 Winter;13(4):271-88. doi: 10.1385/ep:13:4:271. Endocr Pathol. 2002. PMID: 12665646 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous